Biocartesian logo

Biocartesian

Converting biology into digital molecular maps

Summer 2024Healthcare / Healthcare -> Drug Discovery and DeliverySan Francisco, CA, USA2 employees
Hard Tech
B2B
Biotech
Diagnostics
Drug discovery

About

Finding new cures requires seeing what and where the abnormal molecules are in a diseased tissue, but current tools see less than 1% of those molecules. Biocartesian combines microscopy and new chemistries to see 50X more, offering unprecedented insights into disease biology and new therapies.

Founders (2)

Ian Dardani
Founder
Jess Li
Founder

Details

Status
Active
Stage
Early
Team Size
2
Regions
United States of America, America / Canada